Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon.

Ali A SamahaHussein MouawiaMirna FawazHamad HassanAli SalamiAli Al BazzalHamid Bou SaabMohamed Al-WakeelAhmad AlsaabiMohamad ChoumanMahmoud Al MoussawiHassan AyoubAli RaadOla HajjehAli Hussein Eid Houssam Raad

Published in: Viruses (2021)

Ivermectin appears to be efficacious in providing clinical benefits in a randomized treatment of asymptomatic SARS-CoV-2-positive subjects, effectively resulting in fewer symptoms, lower viral load and reduced hospital admissions. However, larger-scale trials are warranted for this conclusion to be further cemented.

Keyphrases

sars cov
clinical trial
respiratory syndrome coronavirus
study protocol
total knee arthroplasty
drug administration
total hip
randomized controlled trial
open label
phase ii
depressive symptoms
double blind
replacement therapy
phase iii
smoking cessation